Status:

COMPLETED

Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia

Lead Sponsor:

University Hospital Erlangen

Conditions:

Leukemia

Lymphoma

Eligibility:

All Genders

Up to 18 years

Phase:

PHASE2

Brief Summary

RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and kill them or carry cancer-killing substances to them. Others interfere with t...

Detailed Description

OBJECTIVES: * Determine the response rate in children and adolescents with B-cell non-Hodgkin's lymphoma (B-NHL) or B-cell acute lymphoblastic leukemia (B-ALL) treated with rituximab monotherapy as u...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Histologically and immunohistochemically OR cytomorphologically and immunphenotypically confirmed mature B-cell non-Hodgkin's lymphoma or B-cell acute lymphoblastic leukemia
  • CD20 positive disease
  • PATIENT CHARACTERISTICS:
  • Not pregnant or nursing
  • Fertile patients must use effective contraception
  • Adequate general condition with sufficient organ function (hepatic, renal, and cardiac)
  • No known disease that would preclude protocol therapy with rituximab
  • No known allergies against proteins
  • No acute or previous hepatitis B infection
  • PRIOR CONCURRENT THERAPY:
  • At least 2 weeks since prior corticosteroids
  • No prior radiotherapy
  • No prior or concurrent chemotherapy
  • No concurrent treatment in another investigational trial

Exclusion

    Key Trial Info

    Start Date :

    March 1 2004

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    Estimated Enrollment :

    79 Patients enrolled

    Trial Details

    Trial ID

    NCT00324779

    Start Date

    March 1 2004

    Last Update

    September 25 2015

    Active Locations (38)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 10 (38 locations)

    1

    Kinderklinik - Universitaetsklinikum Aachen

    Aachen, Germany, D-52074

    2

    Klinikum Augsburg

    Augsburg, Germany, DOH-86156

    3

    Charite - Campus Charite Mitte

    Berlin, Germany, D-10117

    4

    Helios Klinikum Berlin

    Berlin, Germany, D-13125

    Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia | DecenTrialz